(Washington, D.C.) — As the House Committee on Oversight and Reform continues its investigation into drug manufacturers’ pricing strategies, the Pharmaceutical Care Management Association (PCMA) is releasing new data on the impact of blocking competition for top-selling medications. Brand-name drug manufacturers
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released a new report, “Drug Manufacturer Strategies for Keeping Drug Costs High,” on pharmaceutical industry pricing tactics that increase prescription drug costs for patients. The report, conducted by the research firm Visante,
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Health and Human Services Office of Inspector General’s proposed rule on prescription drug rebates in Medicare: “While we are reviewing the proposed
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on today’s action in the House Judiciary Committee on legislation aimed at increasing competition in the prescription drug marketplace. “We applaud the House Judiciary
The pharmacy benefit company market is competitive and diverse, with more than 70 full-service PBMs of varying size operating across the country. These companies differentiate themselves through the services, contract terms, and products they offer. Across this competitive industry is a common mission
High Priced Drugs America’s PBMs are the only member of the prescription drug supply and payment chain working to reduce high drug costs, improve patient access, and increase affordability. PBMs administer prescription drug plans for more than 266 million Americans
(Washington, D.C.) — Today, America’s pharmacy benefit managers (PBMs) released a unified industry statement and set of principles on patient access to prescription drugs during the coronavirus outbreak. The principles set forth by PBMs take into consideration the need for
Proponents of policies targeting pharmacy benefit companies ignore the costly repercussions of undermining pharmacy benefit managers’ (PBMs) ability to secure savings that enable health plan sponsors to offer quality, affordable prescription drug benefits. Proposals being pushed to “lower drug costs” that
Mail-Service Pharmacy Many Americans rely on the mail service pharmacies operated by pharmacy benefit managers (PBMs). Mail-Service Pharmacies provide a convenient, reliable and affordable option for patients to safely access prescription drugs. How does mail-service pharmacy work? Patients may first
©2024 PCMA. All Rights Reserved.
